期刊文献+

熊去氧胆酸治疗原发性胆汁性肝硬化的系统评价 被引量:6

The systematic review on ursodeoxycholic acid for primary biliary cirrhosis
下载PDF
导出
摘要 目的评价长期服用熊去氧胆酸对原发性胆汁性肝硬化的疗效和安全性。方法对全世界熊去氧胆酸与安慰剂对照治疗原发性胆汁性肝硬化的随机对照试验进行系统评价。结果共纳入10个研究,1278例患者。熊去氧胆酸能改善患者的肝功能生化指标,但是不能改善患者的疲劳和瘙痒症状。Meta-分析治疗组与对照组病死率OR值为0.97(95%CI:0.61~1.53)、肝移植率OR值为0.87(95%CI:0.56-1.35)、死亡和/或肝移植OR值为0.96(95%CI:0.69~1.32)、肝病相关死亡率OR值为1.03(95%CI:0.75~1.41)、不良反应事件OR值为1.40(95%CI:0.72~2.71),差异无统计学意义(P〉0.05)。结论熊去氧胆酸虽然可以改善肝功能生化指标,但是不能改善症状,也无足够证据支持熊去氧胆酸延长原发性胆汁性肝硬化患者生存时间。 Objective To assess the long-term efficacy and safety of ursodeoxycholic acid (UDCA) treatment for primary biliary cirrhosis (PBC). Methods A systematic review of all randomized controlled trials (RCT) comparing UDCA with placebo was performed. Results Ten trials including 1 278 patients were assessed. UDCA could significantly improve liver biochemistry, but had no effect on pruritus and fatigue. Meta-analysis showed no significant difference in the incidence of death ( odds ratio 0.97,95% confidence interval 0.61 - 1.53 ), liver transplantation (0.87,0.56 - 1.35 ), death and/or liver transplantation (0.96,0.69 - 1.32), liver related death ( 1.03,0.75 - 1.41 ) and adverse event ( 1.40,0.72 - 2.71 ) between the UDCA and placebo groups. Conclusion The analysis of RCTs of UDCA versus placebo shows improvement of liver biochemistry, but not improvement of clinical symptoms and survival.
出处 《广西医学》 CAS 2009年第2期157-159,共3页 Guangxi Medical Journal
基金 广西教育科学研究基金(桂教科研[2006]26号)
关键词 原发性胆汁性肝硬化 熊去氧胆酸 系统评价 Primary biliary cirrhosis Ursodeoxycholic acid Systematic review
  • 相关文献

参考文献16

  • 1张福奎,贾继东.老年原发性胆汁性肝硬化的临床特点[J].传染病信息,2006,19(3):99-100. 被引量:8
  • 2Jorgensen R, Angulo P, Dickson ER, et al. Result of long-term ursodeoxycholic acid for patients with primary biliary cirrhosis[ J]. Am J Gastroenterol, 2002,97 (10) :2 647 -2 650.
  • 3Renee E,Poupon R, Beverley B. Umodiol for the long-term treatment of primary biliary cirrhosis[ J]. The UDCA-PBC Study Group. N Engl J Med,1994,330(19):1 342-1 347.
  • 4Goulis J, Leandro G, Burroughs AK. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis : a mate-analysis[J].Lancet,1999,354(9 184):1 053-1 060.
  • 5Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [ updated February 2008 ]. The Cochrane Collaboration, 2008. Available from www. cochranehandbook. org[ J/OL ].
  • 6吴泰相,刘关键.隐蔽分组(分配隐藏)和盲法的概念、实施与报告[J].中国循证医学杂志,2007,7(3):222-225. 被引量:174
  • 7Pares A, Caballeria L, Rodes J, et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis:results of a double blind controlled multicentric trial[J]. Hepatology,2000,32(4) :561 -566.
  • 8Poupon RE, Balkau B, Eschwege E, et al. A multicenter,controlled trial of ursodiol for the treatment of primary biliary cirrhosis [ J ]. UDCA-PBC Study Group. N Engl J Med,1991,324 (22):1 548 -1 554.
  • 9Burton Combes, Robert L, Carithers JR, et al. A randomized, double- blind, placebo-controlled trial of ursedeoxycholic acid in primary biliary cirrhosis [ J ]. Hepatology, 1995,22 ( 3 ) : 759 - 766.
  • 10Turner B, Margaret M, Harriet C, et al. A tow year controlled trial examining the effectiveness of ursodeoxycholie acid in primary billary cirrhosis[ J]. Journal of Gastroenterology. and hepatology, 1994, 9 (2) :162 -168.

二级参考文献18

  • 1张福奎,贾继东,王宝恩.老年人原发性胆汁性肝硬化的临床特征[J].中华老年医学杂志,2005,24(1):18-20. 被引量:9
  • 2Marshall MM ,Gershwin ME. Primary biliary cirrhosis[J]. N Engl J Med ,2005,353(25): 1261-1273.
  • 3Lehmann AB, Bassendine MF, James OF. Is primary biliary cirrhosis a different disease in the elderly [J]. Gerontology, 1985,31(3): 186-194.
  • 4Floreani A , Chiaramonte M , Fabris P , et al. Primary biliary cirrhosis in the elderly [J]. Recenti Prog Med , 1991 ,82(5):259-261.
  • 5Newton JL , Jones DE , Metcalf JV , et al. Presentation and mortality of primary biliary cirrhosis in older patients [J]. Age Ageing, 2000,29(4): 305-309.
  • 6Prince M , Chetwynd A , Newman W , et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years[J]. Gastroenterology, 2002, 123(4): 1044-1051.
  • 7Dickson ER , Grambsch PM , Fleming TR , et al. Prognosis in primary biliary cirrhosis: model for decision making[J]. Hepatology, 1959,10(1): 1-7.
  • 8Kim WR , Wiesner RH , Therneau TM , et al. Optimal timing of liver transplantation for primary biliary cirrhosis[J]. Hepatology, 1998,28(1) : 33-38.
  • 9Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines[J]. Hepatology, 2000,31(4): 1005-1013.
  • 10Poupon RE , Bonnard AM , Chretien Y , et al. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis[J]. Hepatology, 1999,29(6): 1668-1671.

共引文献180

同被引文献65

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部